Scientists Estimate Zika-Related Microcephaly Risk

A fetus whose mother is infected with Zika during the first trimester of her pregnancy has a risk of between 1 percent and 13 percent of developing microcephaly, according to a study.

Written byCatherine Offord
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

A baby with microcephaly (left) compared to a baby with a typical-sized head (right)WIKIMEDIA, CDCAn analysis published this week (May 25) in The New England Journal of Medicine has quantified the estimated risk of microcephaly in the developing fetuses of pregnant women infected with Zika virus. Using data from the Zika-hit state of Bahia in Brazil, researchers estimated the risk of microcephaly when mothers were infected during the first trimester of pregnancy to be between 1 percent and 13 percent.

“It is an appreciable risk,” study coauthor Michael Johansson of the US Centers for Disease Control and Prevention (CDC) told The Washington Post. “We need to do whatever we can to help women avoid Zika virus infections during pregnancy.”

In April, the CDC declared that sufficient evidence had accumulated to support a causal link between Zika virus infection and microcephaly and other birth defects; a study published earlier this month provided further support for the link, showing that the virus could cause microcephaly and other defects in developing mouse embryos. However, the present study is one of the first to provide a quantitative estimate of an infant’s risk of microcephaly following maternal infection.

This estimate is the result of an analysis of Zika virus infection ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • After undergraduate research with spiders at the University of Oxford and graduate research with ants at Princeton University, Catherine left arthropods and academia to become a science journalist. She has worked in various guises at The Scientist since 2016. As Senior Editor, she wrote articles for the online and print publications, and edited the magazine’s Notebook, Careers, and Bio Business sections. She reports on subjects ranging from cellular and molecular biology to research misconduct and science policy. Find more of her work at her website.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies